The University of Sheffield announces approval of the first human trial testing regenerative cell therapy to treat sensorineural hearing loss, offering hope for restoring hearing function.
Professor of Neurology Thomas Gasser, JPND’s Scientific Advisory Board Chair and Director of the Department of Neurodegenerative Diseases, shares in an interview JPND’s innovative research and collaboration efforts in the universal race against Alzheimer’s and Parkinson’s diseases.
Dr Faz Chowdhury, CEO at Nemaura Medical (Nasdaq: NMRD), aims to stem the tide of the onset of diabetes and help to manage and reverse Type 2 diabetes using the world’s first daily-wear non-invasive CGM technology.
Michelle Davis, Head of External Relations at Malaria Consortium, shares with us what we need to know about learning from COVID-19 and the continuing fight against malaria.
African swine fever is placed under the spotlight here by Prof. Dr. José Manuel Sánchez-Vizcaíno, Full Professor of Animal Health at Universidad Complutense de Madrid.
Over half of global cardiovascular disease (CVD) deaths in 2019 happened in Asia - now, scientists are drawing attention to rapidly climbing figures, as heart issues continue to be a risk factor for severe COVID.
Earlier this year, Yourgene Health entered into a collaboration with Cytox to run their genoSCORE-LAB assay in our laboratory. genoSCORE-LAB™ is a new non-invasive test that can predict the risk of an individual developing Alzheimer’s disease from a simple saliva sample.
Arun Swaminathan MD, Assistant Professor of Neurology and Epilepsy at the University of Nebraska Med Ctr, explores the need for improved access to epilepsy surgery.
Dr Roderick Corriveau, PhD from the National Institute of Neurological Disorders & Stroke, part of the National Institutes of Health in the U.S., details the importance of understanding the many possible paths to dementia.
Yohei Sasakawa, Chairman of The Nippon Foundation, explores how COVID-19 has given us a glimpse of the lived experience of persons with disabilities and discusses why we have a duty to make the world more inclusive for them.
Neil Wright, on behalf of McGowan Transcriptions UK, discusses the benefits of bilingualism, specifically concerning how speaking more than one language can fight dementia.
Professor Olivier Braissant highlights here, how the challenges of treating genetic diseases can be exemplified by research on creatine transporter deficiency.
Gary Davies, from Sandvik Materials Technology, explains how medical wires are helping patients monitor blood glucose levels without the need for daily testing.
